Apyx Medical Corporation (APYX)

Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.01	31.74	43.65	10.19	30.87	41.92
Cash & Short-Term Investments	31.01	31.74	43.65	10.19	30.87	41.92
Cash Growth	-16.82%	-27.29%	328.30%	-66.98%	-26.35%	-28.73%
Accounts Receivable	11.65	15.58	14.12	10.7	13.14	8.4
Other Receivables	-	-	-	7.64	8.13	8.93
Receivables	11.65	15.58	14.12	18.35	21.26	17.33
Inventory	7.69	7.56	9.92	11.8	6.78	4.05
Prepaid Expenses	1.51	1.56	2.66	2.64	1.83	2.8
Total Current Assets	51.85	56.44	70.36	42.97	60.74	66.09
Property, Plant & Equipment	6.54	6.74	7.15	7.59	6.87	7.22
Other Long-Term Assets	1.77	1.66	1.73	1.22	1.11	0.81
Total Assets	60.16	64.84	79.24	51.78	68.72	74.11
Accounts Payable	2.31	2.62	2.71	2.67	2.63	1.51
Accrued Expenses	6.83	3.46	5.21	3.78	6.69	4.69
Current Portion of Leases	0.37	0.36	0.37	0.25	0.29	0.36
Current Unearned Revenue	-	0.69	0.49	0.85	0.53	-
Other Current Liabilities	-	3.6	3.97	4.3	3.07	2.59
Total Current Liabilities	9.51	10.72	12.74	11.85	13.21	9.15
Long-Term Debt	34.13	33.89	33.19	-	-	-
Long-Term Leases	4.42	4.52	4.95	0.54	0.02	0.31
Long-Term Unearned Revenue	1.19	1.12	1.25	1.41	1.32	0.62
Other Long-Term Liabilities	0.27	0.26	0.2	0.18	0.17	0.17
Total Liabilities	49.52	50.51	52.32	13.98	14.71	10.25
Common Stock	0.04	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	92.53	92.08	81.11	73.28	66.22	61.07
Retained Earnings	-82.06	-77.91	-54.45	-35.74	-12.55	2.62
Total Common Equity	10.51	14.21	26.7	37.58	53.7	63.72
Minority Interest	0.13	0.13	0.22	0.21	0.31	0.14
Shareholders' Equity	10.64	14.34	26.92	37.79	54.01	63.86
Total Liabilities & Equity	60.16	64.84	79.24	51.78	68.72	74.11
Total Debt	38.92	38.76	38.5	0.8	0.31	0.68
Net Cash (Debt)	-7.91	-7.02	5.15	9.4	30.57	41.24
Net Cash Growth	-	-	-45.18%	-69.26%	-25.88%	-28.50%
Net Cash Per Share	-0.21	-0.20	0.15	0.27	0.89	1.21
Filing Date Shares Outstanding	37.79	37.79	34.64	34.6	34.43	34.32
Total Common Shares Outstanding	37.79	37.79	34.64	34.6	34.41	34.29
Working Capital	42.34	45.72	57.62	31.12	47.53	56.94
Book Value Per Share	0.28	0.38	0.77	1.09	1.56	1.86
Tangible Book Value	10.51	14.21	26.7	37.58	53.7	63.72
Tangible Book Value Per Share	0.28	0.38	0.77	1.09	1.56	1.86
Land	-	-	-	1.6	1.6	1.6
Buildings	-	-	-	4.43	4.43	4.45
Machinery	-	5.06	4.83	5.09	5.04	4.72
Construction In Progress	-	0.64	0.4	0.51	0.65	0.42
Leasehold Improvements	-	0.28	0.21	0.18	0.17	0.16

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q